Drawing for DNAVEC CORPORATION

USPTO serial 79026712

DNAVEC CORPORATION

Reviewed by CopyMark Law Group

Reg. 3280182Status 404
Filing date
Status date
Registration date
Aug 14, 2007
Examiner
HAYES, GINA CLARK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DNAVEC CORPORATION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

COREY K. CHO

COREY K. CHO SALIWANCHIK, LLOYD & SALIWANCHIKP.O. BOX 142950GAINESVILLE, FL 32614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents for non-medical purposes; protein plastic, plastic arrays and nucleotide arrays for scientific and medical research, not for medical or veterinary purposes; enzymes substrates; biochemicals, namely, polypeptides, and poly nucleotides for in vitro research use; chemical reagents comprising antibodies for non-medical purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific research reagent, cosmetics, and pharmaceuticalsSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of cancer and sarcoma; contrasting agent for X-ray imaging; diagnostic reagents for medical purpose; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccine; biological preparations for medical purposes; preparations for introducing genes for medical purposes; vaccines; gene vaccines; RNA vectors for medical and laboratory use, namely for gene therapySECTION 71 - CANCELLED—
009Laboratory apparatus, namely, centrifuges, crucibles, incubators, spectroscopes, and pipette racks; laboratory instruments, namely pipettes, test tubes, and test tube racks; measuring instrumentation and apparatus, namely digitizers; computers comprising central processing units and electronic circuits, blank magnetic discs for computers, blank magnetic computer tapes, and computer peripheralsSECTION 71 - CANCELLED—
010Diagnostic apparatus and instruments, namely, electromagnetic medical diagnostic imaging apparatus, nuclear medicine diagnostic imaging apparatus, and ultrasound diagnostic apparatus; medical X-ray apparatusSECTION 71 - CANCELLED—
041Education services, namely providing classes, seminars, and workshops in the field of medicine, pharmaceuticals, biochemistry, and human genomics; arranging of seminars and organization of conferences and symposia in the field of medicine and pharmaceuticals; providing workshops in the field of medicine and pharmaceuticalsSECTION 71 - CANCELLED—
042Testing, inspection, research, or development of pharmaceuticals, cosmetics, or foodstuffs; testing, inspection, research, or development of pharmaceutical preparations for gene therapy; testing inspection, research, or development of vaccines; medical research of recombinant proteins; chemical, biochemical, biological and bacteriological research and functional analysis of genes or proteins; scientific research in the field of genetics and genetic engineering for manufacturing genetically engineered animals, plants, and vectors; research and development of new vector technology for others in the field of genomics, biotechnology, pharmacology and medical science; testing, inspection, or research on agriculture, livestock breeding, or fisheries; research and development of chemicals for life science; research on machines and instruments in the field of genomics, biotechnology, pharmacology and medical science; computer software design; computer programming; maintenance of computer software; rental of computers or providing temporary use of online non-downloadable software for use in database management in the field of genomics, biotechnology, pharmacology and medical scienceSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 4, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Nov 4, 2016DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 1, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 12, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 29, 2015XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Apr 29, 2015XXCRGENERIC MADRID TRANSACTION CREATED—
Nov 21, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 14, 2014GPNXNOTIFICATION PROCESSED BY IB—
Mar 21, 2014C71TCANCELLED SECTION 71—
Nov 11, 2011ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 27, 2009FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 12, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 11, 2007FIMPFINAL DISPOSITION PROCESSED—
Nov 28, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 14, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 29, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 9, 2007NPUBNOTICE OF PUBLICATION—
Mar 28, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 28, 2007ALIEASSIGNED TO LIE—
Mar 3, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 28, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 27, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 13, 2006RFNTREFUSAL PROCESSED BY IB—
Sep 21, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 21, 2006RFRRREFUSAL PROCESSED BY MPU—
Sep 19, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 18, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2006DOCKASSIGNED TO EXAMINER—
Sep 8, 2006NWAPNEW APPLICATION ENTERED—
Sep 7, 2006REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance